COVID-19
Showing NaN - NaN of 36
COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)
Terminated
- COVID-19
- Apixaban 2.5 MG
- +3 more
-
Los Angeles, California
- +70 more
Feb 15, 2022
COVID-19 Trial in United States (Brequinar, Standard of Care)
COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)
COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)
Completed
- COVID-19
- PUL-042 Inhalation Solution
- Placebo
-
Orange, California
- +14 more
Sep 1, 2021
COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)
Completed
- COVID-19
- PUL-042 Inhalation Solution
- Placebo
-
Orange, California
- +10 more
Jul 14, 2021
COVID-19, Viral Respiratory Illnesses Trial in United States (Nitazoxanide, Placebo, Vitamin Super B-Complex)
Unknown status
- COVID-19
- Viral Respiratory Illnesses
- Nitazoxanide
- +2 more
-
Hot Springs, Arkansas
- +25 more
Feb 5, 2021
COVID-19 Trial in Poland, United States
Enrolling by invitation
- COVID-19
-
Batesville, Arkansas
- +10 more
Oct 21, 2020
COVID-19, Acute Respiratory Distress Syndrome, Acute Respiratory Failure Trial in Tampa, Fort Worth (Sodium Nitrite, Normal
Withdrawn
- COVID-19
- +2 more
- Sodium Nitrite
- Normal Saline
-
Tampa, Florida
- +1 more
Sep 11, 2020